ORTHOSOFT INC.Download PDFPatent Trials and Appeals BoardJan 28, 20212020003958 (P.T.A.B. Jan. 28, 2021) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 15/968,868 05/02/2018 Di LI 05015228-129US-1 8709 93758 7590 01/28/2021 NORTON ROSE FULBRIGHT CANADA LLP (Zimmer Cas) 1 Place Ville Marie Suite 2500 Montreal, QUEBEC H3B 1R1 CANADA EXAMINER LAWSON, MATTHEW JAMES ART UNIT PAPER NUMBER 3775 NOTIFICATION DATE DELIVERY MODE 01/28/2021 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): NRFCUSPTOMAIL@nortonrosefulbright.com ipcanada@nortonrose.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte DI LI, LOUIS-PHILIPPE AMIOT, HERBERT ANDRE JANSEN, FRANCOIS PARADIS, ISABELLE ROBITAILLE, BRUNO FALARDEAU, KARINE DUVAL, MYRIAM VALIN, YVAN LEONE, YONIK BRETON, BENOIT PELLETIER, MATHIEU CHEVRIER, and JEROME CASAUBON Appeal 2020-003958 Application 15/968,868 Technology Center 3700 Before JILL D. HILL, LEE L. STEPINA, and ARTHUR M. PESLAK, Administrative Patent Judges. STEPINA, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Pursuant to 35 U.S.C. § 134(a), Appellant1 appeals from the Examiner’s decision to reject claims 1 and 3–10. See Final Act. 1. We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM IN PART and enter a NEW GROUND OF REJECTION pursuant to 37 C.F.R. § 41.50(b). 1 We use the word Appellant to refer to “applicant” as defined in 37 C.F.R. § 1.42. Appellant identifies the real party in interest as Orthosoft, ULC. Appeal Br. 2. Appeal 2020-003958 Application 15/968,868 2 CLAIMED SUBJECT MATTER Appellant’s invention relates to an acetabular cup prosthesis positioning instrument and system. Claims 1 and 6 are independent. Claim 6, reproduced below, is illustrative of the claimed subject matter: 6. A system comprising: a cup impactor including a shaft, a cup coupler at a cup end of the shaft adapted to releasably connect a cup in fixed relation for subsequent impacting, a handle at an impacting end of the shaft, a visual guide mounted to at least one of the shaft and the handle, the visual guide producing visual guidance toward at least one anatomical landmark of a pelvis; and an inertial sensor unit configured for producing at least an orientation output related to an orientation of the cup impactor, the inertial sensor unit including a processor and a program executable by the processor and including: calibration data based on a planned geometric relation between an initial reference orientation of the cup impactor assembly and the at least one anatomical landmark of the pelvis as aligned with the visual guidance of the visual guide, the calibration data for calibrating the inertial sensor unit relative to the pelvis for the inertial sensor unit to produce said orientation output, and a desired acetabular cup orientation data based on preoperative planning. REFERENCES The prior art relied upon by the Examiner is: Name Reference Date Taylor US 2009/0099665 A1 Apr. 16, 2009 Sherman US 2014/0276871 A1 Sept. 18, 2014 Appeal 2020-003958 Application 15/968,868 3 REJECTIONS I. Claims 6 and 7 are rejected under 35 U.S.C. § 102(a)(2) as being anticipated by Sherman. II. Claims 1, 3–5, and 8–10 are rejected under 35 U.S.C. § 103 as unpatentable over Sherman and Taylor. OPINION Rejection I; Anticipation Based on Sherman Appellant argues, inter alia, that Sherman does not use “preoperative planning” because each of the steps disclosed by Sherman occur after surgery has begun. Appeal Br. 7. Specifically, Appellant asserts that step 812 of Sherman, upon which the Examiner relies, is performed as part of a conventional intraoperative approach. Id. The Examiner responds that, because Sherman’s surgeon selects the type of surgery to be performed, the selection is performed before the surgery. Ans. 3. According to the Examiner, because Appellant does not specifically define “preoperative,” the surgeon determining a type of surgery after exposure of a surgical site, but prior to actually performing the intended surgical procedure is preoperative planning. Ans. 3–4. Appellant replies that defining the steps of placing the patient on the operating table and making incisions to expose the acetabulum as preoperative planning “defies plain logic and is simply contrary to general definitions in the art.” Reply Br. 2. Appellant has the better position. Appellant’s Specification describes preoperative planning as including obtaining a model of the patient’s hip using “any appropriate imaging technique.” Spec. ¶¶ 30–32. After the model is obtained, intraoperative steps are performed including placing the Appeal 2020-003958 Application 15/968,868 4 patient in position and then exposing the acetabulum. Spec. ¶¶ 33–35. The acetabular cup is then oriented based on the preoperative planning. Spec. ¶¶ 35, 38, 40. Accordingly, the broadest reasonable interpretation in light of the Specification of the term “preoperative planning” requires the planning to be performed prior to any intraoperative step including exposing the acetabulum. The Examiner does not provide evidence or persuasive reasoning to support the position that preoperative planning includes exposing the surgical site. Indeed, Sherman describes that method 800 in which surgery is performed on the acetabulum “begins with block 802 in which an orthopedic surgeon exposes the surgical site.” Sherman ¶ 66; see also Appeal Br. 7. Thus, the Examiner’s interpretation of claim 6 is unreasonably broad. This unreasonably broad claim interpretation led the Examiner to find that Sherman discloses using orientation data based on preoperative planning. Under the broadest reasonable interpretation of claim 6, in light of the Specification, this finding is not supported by a preponderance of the evidence. Accordingly, Appellant’s argument on this point is persuasive, and we do not sustain the rejection of claim 6 and associated dependent claim 7 as being anticipated by Sherman. Rejection II; Obviousness Based on Sherman and Taylor Claims 1 and 3–5 Like claim 6, claim 1 recites, inter alia, orientation data based on preoperative planning. See Appeal Br. 11 (Claims App.). However, unlike claim 6, which recites “the inertial sensor unit including a processor and a program executable by the processor and including” the claimed orientation Appeal 2020-003958 Application 15/968,868 5 data, claim 1 merely requires that the inertial sensor unit has a “patient- specific file comprising” the data. Id. In the rejection of claim 1, the Examiner makes the same findings regarding the teachings of Sherman. See Final Act. 4. In particular, the Examiner finds that Sherman discloses a shaft 140, a cup coupler 132, a handle 138, and an inertial sensor unit 104 having a patient-specific file comprising the claimed data. Id. The Examiner relies on Taylor to disclose a light projector. Id. at 5. Appellant argues that “[t]he argument for claim 6 is applied mutatis mutandis to the rejection of claim 1. Sherman does not describe the claimed limitations of ‘preoperative planning’, ‘planned geometric relation’, and ‘calibration data’ of claim 6.” Appeal Br. 9. According to Appellant, “Taylor does not make up the deficiencies of Sherman.” Id. In our review of Sherman and Taylor, we find the references teach everything recited in claim 1 except the limitations “calibration data based on a planned geometric relation” and “orientation data based on preoperative planning,” as argued by Appellant. Appellant does not argue that Sherman fails to teach that the inertial sensor unit has a patient-specific file. Rather, Appellant argues that although the claimed “preoperative planning data is data obtained preoperatively such as by a surgeon . . . Sherman focuses on an intraoperative method.” Reply Br. 2. We understand that, in Sherman, the orientation sensor data (Sherman ¶ 71) generated by the inserter sensor module 104 (non-functional descriptive material) is data, but not the specific type of data recited, namely, “preoperative planning data.” Similarly, Sherman’s alignment sensor data (Sherman ¶¶ 74–75) is data, but is not Appeal 2020-003958 Application 15/968,868 6 “based on a planned geometric relation.” Therefore, Sherman does not explicitly teach the data is planned or obtained during preoperative planning. Our reviewing court has held that non-functional descriptive material cannot lend patentability to an invention that would have otherwise been anticipated by the prior art. In re Ngai, 367 F.3d 1336, 1339 (Fed. Cir. 2004). Cf. In re Gulack, 703 F.2d 1381, 1385 (Fed. Cir. 1983) (noting that when descriptive material is not functionally related to the substrate, the descriptive material will not distinguish the invention from the prior art in terms of patentability). King Pharms., Inc. v. Eon Labs, Inc., 616 F.3d 1267, 1279 (Fed. Cir. 2010) (“[T]he relevant question is whether ‘there exists any new and unobvious functional relationship between the printed matter and the substrate.”’) (citations omitted). See also In re Xiao, 462 Fed. Appx. 947, 950–52 (Fed. Cir. 2011) (Non-precedential) (Non-functional descriptive material, being useful and intelligible only to the human mind, is given no patentable weight). Appellant argues that the claimed preoperative planning data recited in claim 1 patentably distinguishes over the prior art data obtained intraoperatively. We disagree because in claim 1, the data obtained is not functionally related to its substrate inasmuch as it is not executed by a processor and does not otherwise affect the function of the cup impactor assembly. Rather, the data recited in claim 1 is merely stored in a “patient- specific file.” Therefore, we determine that the disputed claim limitation constitutes non-functional descriptive material (“NFDM”) and is not entitled to patentable weight. This is analogous to Curry, where the type of data was found to be non-functional descriptive material when it “does not Appeal 2020-003958 Application 15/968,868 7 functionally change either the data storage system or communication system used in the method of claim 81.” Ex parte Curry, 84 USPQ2d 1272, 1274 (BPAI 2005) (informative), aff’d, No. 2006-1003 (Fed. Cir. June 12, 2006) (Rule 36) (“Nonfunctional descriptive material cannot render nonobvious an invention that would have otherwise been obvious.”). As a result, in claim 1, Appellant’s claimed preoperative planning data does not distinguish his invention from the prior art. This is in contrast to claim 6, which recites structure, i.e., a processor programmed to perform an algorithm for carrying out the recited function of producing an orientation output. See Appeal Br. 12 (Claims App.); Spec. ¶ 38. To find otherwise would mean that each novel set of data that is merely stored on a device is sufficient to warrant a separate patent for a device, even if the remainder of the invention is unchanged. This would result not only in Appellant’s preoperative data distinguishing over the prior art, but equally the same assembly recited in claim 1 having a file containing a patient’s phone number, age, or other information distinguishing over the prior art. To give effect to such an interpretation, we would need to ignore our reviewing court’s concerns with repeated patenting. The rationale behind this prior art rejection is preventing the repeated patenting of essentially a known product by the mere inclusion of novel non- functional descriptive material. King Pharms., 616 F.3d at 1279 (“The rationale behind this line of cases is preventing the indefinite patenting of known products by the simple inclusion of novel, yet functionally unrelated limitations.”) Cf. In re Ngai, 367 F.3d at 1339 (“If we were to adopt Ngai’s position, anyone could continue patenting a product indefinitely provided that they add a new instruction sheet to the product.”). Appeal 2020-003958 Application 15/968,868 8 We agree with the Examiner that the subject matter of claim 1 would have been obvious based on the combined teachings of Sherman and Taylor because the Examiner’s proposed combination of the disclosures of these references teaches each and every limitation of the claim. Any argued difference between the prior art and the claimed invention is simply a substitution of one piece of NFDM (preoperative data) for another piece of NFDM (intraoperative data), which does not change the functioning of the claimed cup impactor assembly. Therefore, we sustain the Examiner’s rejection of claim 1, and claims 3–5 depending therefrom, as unpatentable over Sherman and Taylor. However, due to the extent to which our interpretation of claim 1 differs from the Examiner’s (see Final Act. 4; see also Ans. 3), we designate our affirmance a NEW GROUND OF REJECTION to afford Appellant a full and fair opportunity to react to the thrust of the rejection. See In re Kronig, 539 F.2d 1300, 1302 (CCPA 1976) (“the ultimate criterion of whether a rejection is considered ‘new’ in a decision by the board is whether appellants have had [a] fair opportunity to react to the thrust of the rejection.”). Claims 8–10 Claims 8–10 depend from claim 6. Appeal Br. 12–13 (Claims App.). The Examiner’s use of Taylor does not remedy the deficiency discussed above regarding claim 6. See Final Act. 4–5. Accordingly, for the same reasons, we do not sustain the rejection of claims 8–10. CONCLUSION The Examiner’s rejections are affirmed in part. Appeal 2020-003958 Application 15/968,868 9 DECISION SUMMARY Claims Rejected 35 U.S.C. § Reference(s)/Basis Affirmed Reversed New Ground 6, 7 102(a)(2) Sherman 6, 7 1, 3–5, 8–10 103 Sherman, Taylor 1, 3–5 8–10 1, 3–5 Overall Outcome 1, 3–5 6–10 1, 3–5 TIME PERIOD FOR RESPONSE This decision contains a new ground of rejection pursuant to 37 C.F.R. § 41.50(b). 37 C.F.R. § 41.50(b) provides “[a] new ground of rejection pursuant to this paragraph shall not be considered final for judicial review.” 37 C.F.R. § 41.50(b) also provides that the Appellant, WITHIN TWO MONTHS FROM THE DATE OF THE DECISION, must exercise one of the following two options with respect to the new ground of rejection to avoid termination of the appeal as to the rejected claims: (1) Reopen prosecution. Submit an appropriate amendment of the claims so rejected or new Evidence relating to the claims so rejected, or both, and have the matter reconsidered by the examiner, in which event the prosecution will be remanded to the examiner. . . . (2) Request rehearing. Request that the proceeding be reheard under §41.52 by the Board upon the same Record. . . . Further guidance on responding to a new ground of rejection can be found in the Manual of Patent Examining Procedure § 1214.01 (9th Ed., Rev. 10.2019, June 2020). Appeal 2020-003958 Application 15/968,868 10 No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.136(a)(1)(iv) (2019). AFFIRMED IN PART; 37 C.F.R. § 41.50(b) Copy with citationCopy as parenthetical citation